Ryan Zimmerman Analyst PerformanceManaging Director at BTIG ResearchRyan Zimmerman is a stock analyst at BTIG Research in the medical sector, covering 22 publicly traded companies. Over the past year, Ryan Zimmerman has issued 15 stock ratings, including buy and hold recommendations. While full access to Ryan Zimmerman's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ryan Zimmerman's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings70 Last 8 YearsBuy Recommendations82.09% 55 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution67RatingsDistribution of strong buy, buy, hold, and sell ratings by Ryan Zimmerman.RatingPercentageCount Strong Buy0.0%0 ratings Buy82.1%55 ratings Hold17.9%12 ratings Sell0.0%0 ratingsOut of 67 total stock ratings issued by Ryan Zimmerman at BTIG Research, the majority (82.1%) have been Buy recommendations, followed by 17.9% Hold.Best & Worst CallsBest Call0000.0%VCELAug 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CFMSDec 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ72.7% of companies on NASDAQ16 companiesNYSE27.3% of companies on NYSE6 companiesRyan Zimmerman, an analyst at BTIG Research, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical22 companies100.0%Ryan Zimmerman of BTIG Research specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED INSTRUMENTS12 companies54.5%MED - BIOMED/GENE2 companies9.1%MED PRODUCTS2 companies9.1%MEDICAL DEVICES2 companies9.1%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company4.5%MED/DENTAL - SUPP1 company4.5%MED - DRUGS1 company4.5%SURGICAL & MEDICAL INSTRUMENTS1 company4.5% About Ryan ZimmermanRyan Zimmerman is a Managing Director and Medical Technology Analyst at BTIG. He provides coverage across the medical technology sector, focusing primarily on orthopedic and surgical companies. Prior to BTIG, Mr. Zimmerman was a Senior Associate at Canaccord Genuity, providing medical technology coverage with an emphasis on musculoskeletal companies. Previously, he was the Director of Surgery at Advocate Christ Medical Center, where he oversaw operations for a Level 1 Trauma hospital in the Chicago area. Mr. Zimmerman also held hospital management roles at Presence Health, and was a Fellow in Hospital Management at the University of Pennsylvania Health System. He is board certified in hospital management, and is a Fellow in the American College of Healthcare Executives. Mr. Zimmerman earned a BS in anthropology and zoology from the University of Michigan, and a Masters of Healthcare Administration from the University of Illinois-Chicago School of Public Health.Follow on LinkedIn Ryan Zimmerman's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsVCELVericel9/17/2025Downgrade$33.23Neutral$0.0000.00% ROIPRCTPROCEPT BioRobotics9/16/2025Reiterated Rating$38.00Neutral$0.0000.00% ROIGKOSGlaukos9/10/2025Reiterated Rating$90.86$118.00Buy$0.0000.00% ROISIShoulder Innovations9/9/2025Reiterated Rating$15.18$23.00Buy$0.0000.00% ROIKIDSOrthoPediatrics8/6/2025Lower Price Target$17.66$39.00Buy$0.0000.00% ROIISRGIntuitive Surgical7/23/2025Boost Price Target$511.00$571.00Buy$0.0000.00% ROIISRGIntuitive Surgical7/14/2025Set Price Target$518.35$566.00Buy$0.0000.00% ROIALCAlcon7/14/2025Set Price Target$87.45$100.00Buy$0.0000.00% ROIRXSTRxSight7/9/2025Reiterated Rating$12.79Neutral$0.0000.00% ROIGMEDGlobus Medical5/27/2025Reiterated Rating$59.00Neutral$0.0000.00% ROISYKStryker4/14/2025Set Price Target$346.69$403.00Buy$0.0000.00% ROIISRGIntuitive Surgical4/14/2025Set Price Target$481.34$560.00Buy$0.0000.00% ROIGEHCGE HealthCare Technologies4/14/2025Set Price Target$61.48$95.00Buy$0.0000.00% ROIISRGIntuitive Surgical10/18/2024Set Price Target$521.89$535.00$0.0000.00% ROIHUMAHumacyte10/18/2024Reiterated Rating$5.24$10.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.